A randomized controlled clinical trial to evaluate the efficacy of Bilwadi ghanvati in Medoroga with special refrence to obesity(class 1)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 74
- 试验地点
- 1
- 主要终点
- To study the effect of Bilwadi ghanavati on reducing BMI in obesity (class 1)subjects.
研究概览
简要总结
Obesity is becoming major worldwide problem and growing day by day known as global epidemic and is the major and basic cause of lifestyle disorders like cardiovascular diseases, diabetes mellitus(T2DM), hypertension, stroke, musculoskeletal disorders, liver diseases, Cancer etc. In modern medicine there is no any effective medicine to control or permanent cure for obesity. Diet, moderate exercises and behavioural modification are first line management.Today it is need to find the drug which is cost effective, easily available everywhere and easy to follow one such preparation is Bilwadi kwath mention in Sharangdhar samhita having properties like kaphagna, medohara. Bilwadi kwath has Ushna, Laghu, Ruksha Guna and Deepana, Kapha-vata Hara and Medohara Karma expected to increase the power of Rasa and Meda Dhatvagni, decrease in Kapha and Vata and thus decrease in further formation of Aama, Meda Dhatu and its deposition in body results in an improvement in Medoroga.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
入选标准
- •Patient Having BMI Ranging Between 30-34.9kg/M2 I.E., Obesity (Class 1) 2) Patient Between Age Group 20-50 Yrs ,Irrespective Of Gender.
- •Patient Having Sign And Symptoms Of Sthaulya Kshudra Shwas, Kshudhatimatra,Pipasadhikya,Swedadhikya,Atinidra,Daurgandha ,Daurbalya.
- •Patients Of Both Gender 5) Patients Willing For Trial And Giving Written Consent.
排除标准
- •BMI less Than 30 and More Than 35 2) Patients is known case of cardiac , pulmonary,renal and hepatic diseases, etc. 3) Patients having medical emergencies associated with like Coronary Heart disease, Atherosclerosis, Myocardial infarction etc. 4) Pregnant females and lactating women. 5) Patients having known case of diabetic mellitus, thyroid disorder and HTN, and other endocrine disease. 6) Overweight due to drug eg.
- •corticosteroids.
结局指标
主要结局
To study the effect of Bilwadi ghanavati on reducing BMI in obesity (class 1)subjects.
时间窗: 12 weeks
次要结局
- To study tolerance of Bilwadi ghanavati in Medoroga with respect to(obesity (class1) subjects for 90 days)
研究者
Dr Pooja Sodgir
ASS, Ayurvedic Mahavidyala Nashik